Doravirine and Weight Gain in Antiretroviral Naive

Clinical trial NCT05457530 · WITHDRAWN

Trial details

NCT number: NCT05457530
Sponsor: Prism Health North Texas
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Body Weight Changes Human Immunodeficiency Virus ART Obesity Minority Health BMD Metabolic Syndrome Fasting

Start date: 2022-08-01
Primary completion: 2023-05-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.